:

Lawrence Mbuagbaw1,2,3, Behnam Sadeghirad2,3,4, Rebecca L Morgan2,5,6

  • 1Biostatistics Unit/The Research Institute, St Joseph's Healthcare, Hamilton, ON, Canada.

概括

的治疗失败,影响15.2%的患者,因地区和时间而异. 与单次剂量相比,第二剂艾弗梅克丁显著降低了失效率.